Last reviewed · How we verify
Ross River Virus Vaccine
Ross River Virus Vaccine works by stimulating the body's immune system to produce a protective response against Ross River virus infection.
Ross River Virus Vaccine works by stimulating the body's immune system to produce a protective response against Ross River virus infection. Used for Prevention of Ross River virus infection.
At a glance
| Generic name | Ross River Virus Vaccine |
|---|---|
| Sponsor | Alachua Government Services, Inc. |
| Modality | Biologic |
| Therapeutic area | Infectious Diseases |
| Phase | Phase 3 |
Mechanism of action
The vaccine contains a weakened or inactivated form of the Ross River virus, which triggers an immune response without causing the disease. This immune response helps the body to recognize and fight off future infections.
Approved indications
- Prevention of Ross River virus infection
Common side effects
- Pain, redness, or swelling at the injection site
Key clinical trials
- Ross River Virus (RRV) Vaccine Study (PHASE3)
- Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine (PHASE1, PHASE2)
- Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801 (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ross River Virus Vaccine CI brief — competitive landscape report
- Ross River Virus Vaccine updates RSS · CI watch RSS
- Alachua Government Services, Inc. portfolio CI